Found: 5
Select item for more details and to access through your institution.
Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 657, doi. 10.1111/apt.14474
- By:
- Publication type:
- Article
Editorial: measuring inflammatory and fibrotic components of portal hypertension - a non-invasive hepatic venous pressure gradient? Authors' reply.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis ( ELF) score predicts clinically significant portal hypertension in patients with cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 11, p. 1222, doi. 10.1111/apt.13618
- By:
- Publication type:
- Article
Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 2, p. 173, doi. 10.1111/j.1365-2036.2012.05134.x
- By:
- Publication type:
- Article
Do all patients with type 2 diabetes need breakfast?
- Published in:
- European Journal of Clinical Nutrition, 2011, v. 65, n. 6, p. 761, doi. 10.1038/ejcn.2011.18
- By:
- Publication type:
- Article